title: Neuroendocrine carcinoma of the larynx - an extraordinary malignancy with high recurrence rates and long survival: our experience in 11 patients.
authors.forename: T P
authors.initials: TP
authors.lastname: van der Laan
authors.forename: B F A M
authors.initials: BF
authors.lastname: van der Laan
authors.forename: B E C
authors.initials: BE
authors.lastname: Plaat
authors.forename: J
authors.initials: J
authors.lastname: Wedman
authors.forename: B M
authors.initials: BM
authors.lastname: Van Hemel
authors.forename: G B
authors.initials: GB
authors.lastname: Halmos
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D018278:Carcinoma, Neuroendocrine / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007822:Laryngeal Neoplasms / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology*; D009367:Neoplasm Staging; D009426:Netherlands; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate / Q000639:trends; D013997:Time Factors